Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
TG-01 by Circio Holding for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
TG-01 is under clinical development by Circio Holding and currently in Phase II for Pancreatic Ductal Adenocarcinoma. According to GlobalData,...
Data Insights
TG-01 by Circio Holding for Non-Small Cell Lung Cancer: Likelihood of Approval
TG-01 is under clinical development by Circio Holding and currently in Phase II for Non-Small Cell Lung Cancer. According to...